Asmanex FDA Approval History
FDA Approved: Yes (First approved March 30, 2005)
Brand name: Asmanex
Generic name: mometasone furoate
Dosage form: Inhalation Powder
Company: Schering-Plough Corporation
Treatment for: Asthma
Asmanex Twisthaler (mometasone furoate) is an inhaled corticosteroid for the treatment of asthma.
Development Timeline for Asmanex
|Feb 4, 2008||FDA Approves Asmanex Twisthaler (Mometasone Furoate InhalationPowder) for the Once Daily Maintenance Treatment of Asthma inChildren Ages 4-11|
|Mar 30, 2005||FDA Approves Asmanex Twisthaler for Asthma|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.